Efficacy and safety of ripretinib in patients with KIT-altered metastatic melanoma
瑞普替尼治疗KIT基因改变的转移性黑色素瘤患者的疗效和安全性
期刊:ESMO Open
影响因子:8.3
doi:10.1016/j.esmoop.2022.100520
Janku, F; Bauer, S; Shoumariyeh, K; Jones, R L; Spreafico, A; Jennings, J; Psoinos, C; Meade, J; Ruiz-Soto, R; Chi, P